Monday, October 28, 2019
"The Role of Cancer Cell Metabolism in Shaping the Tumor Microenvironment"
Session 1: RISK FACTORS AND METABOLISM
Co-Chairs: Tim Greten, M.D. & Mitchell Ho, Ph.D.
"Bacterial translocation and risk of liver cancer in two populations"
"Alcohol Metabolism, Alcoholic Liver Disease and Cancer"
"NonAlcoholic Fatty Liver Disease and Liver Cancer"
“Nonalcoholic fatty liver disease impairs efficacy of T cell-based immunotherapies for liver metastases in mice”
"Hepatitis C Virus: The Bogeyman, a Metabolic Rubicon and Liver Cancer"
"Discerning liver tumor subtypes with altered obesity-related metabolism"
"Liver Stress kinases – crossroad between obesity and liver cancer"
Lunch (on your own)
Session 2: MICROBIOME, IMMUNE BIOLOGY AND METABOLISM
Co-Chairs: Frank Gonzalez, Ph.D. & Giorgio Trinchieri, M.D.
"How does the microbiome and fatty liver disease control anti-tumor immunity?"
“The missing link? To the portal vein and beyond”
"Interplay Between Dietary Fiber and Gut Microbiota in Liver Cancer: The Dark Side of Fermentation"
"MicroRNA-223 in nonalcoholic steatohepatitis and cancer"
"The commensal gut microbiota restrict metastatic tumor growth in the liver"
"Role of FGF15 in promoting liver regeneration"
"Metabolic Niches in Cancer and Inflammation"
"Sugar, Th17 cell and mucosal inflammation"
Tuesday, October 29, 2019
Session 3: GENETICS, GENOMICS and METABOLISM
Co-Chairs: Xin Wang, Ph.D. & Natalie Porat-Shliom, Ph.D.
"Translating Liver Cancer Biology: From functional Target Discovery to Academic Drug Development"
"The Exosomes in Immune Suppression and Tumor Progression"
"Beta-catenin Mutations in Hepatocellular Cancer: Implications in Tumor Metabolism and Therapy"
"Tumor Methionine Metabolism Drives T Cell Dysfunction In Hepatocellular Carcinoma"
"FBP1 as a metabolic tumor suppressor in liver cancer"
"Natural history of liver tumors revisited by genomics"
"Preclinical modeling of targeted therapies for cholangiocarcinoma"
"Magnetic resonance imaging of tumor metabolism"